FDA and pharma seek better ways to assess drug safety, efficacy in clinical trials.
M. Mitka. JAMA : the journal of the American Medical Association, 307 (24):
2576-7(June 2012)6793<m:linebreak></m:linebreak>JID: 7501160; ppublish;<m:linebreak></m:linebreak>Intention to treat.
DOI: 10.1001/jama.2012.6684